CIENCIASMEDICASNEWS: Medical News | Medical Articles: Estrogen as a Treatment for Parkinson’s Disease

lunes, 6 de enero de 2020

Medical News | Medical Articles: Estrogen as a Treatment for Parkinson’s Disease

	Parkinson's Disease
	The latest Parkinson's disease news from News Medical

Estrogen as a Treatment for Parkinson’s Disease

It is thought that estrogen may be protective in the Parkinson’s disease is a neurodegenerative disorder clinically characterized by dyskinesia (impairment of movement), resting tremor, bradykinesia (slow movements), dystonia (stiffness of muscles including facial muscles), a stooped posture, drooling, sexual and urinary dysfunction, and in some cases psychiatric symptoms including psychosis, dementia, and depression.

			Vitamin D supplementation may help treat non-motor symptoms related to Parkinson's disease In an Acta Neurologica Scandinavia study of 182 patients with Parkinson's disease and 185 healthy controls, patients with Parkinson's disease had significantly lower levels of vitamin D in their blood.

			Johns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptoms In a new study of seven people with Parkinson’s disease, Johns Hopkins Medicine researchers report evidence that deep brain stimulation using electrical impulses jumpstarts the nerve cells that produce the chemical messenger dopamine to reduce tremors and muscle rigidity that are the hallmark of Parkinson’s disease, and increases feelings of well-being.

	Estrogen could be viable treatment option for Parkinson's patients Brain-selective estrogen treatment improves the symptoms of Parkinson’s disease in male mice, according to new research published in JNeurosci. These findings may help explain the sex differences in Parkinson’s disease and could lead to estrogen-based treatments.

	Genetic engineering could open possibilities for patients with Parkinson’s disease People with Parkinson’s disease experience loss of dopamine-producing brain cells, leading to tremors, rigidity, bradykinesia, and postural instability, the primary symptoms of the disease.

	Researchers move closer to new screening technology for early detection of Parkinson's disease Screening technology to catch Parkinson's disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.

	A new kind of testing for patients with Parkinson's disease Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.

	Research reveals increased inflammatory activity in patients with frontotemporal dementia Recent research from the University of Eastern Finland revealed increased inflammatory activity in a subgroup of patients with frontotemporal dementia. Increased inflammation was associated with parkinsonism symptoms and more rapid disease progression.